Independent walking and cognitive development in preschool children with Dravet syndrome

Karen Verheyen, Lore Wyers, Alessandra Del Felice, An-Sofie Schoonjans, Berten Ceulemans, Patricia Van de Walle, Ann Hallemans, Karen Verheyen, Lore Wyers, Alessandra Del Felice, An-Sofie Schoonjans, Berten Ceulemans, Patricia Van de Walle, Ann Hallemans

Abstract

Aim: To investigate the relation between cognitive and motor development in preschool aged children with Dravet syndrome, in particular between the age of independent walking and cognitive development.

Method: Results of cognitive and motor developmental assessments and the age of independent walking were retrieved retrospectively from the medical records of 33 children (17 males, 16 females; mean age at last evaluation 33.2mo, SD 8.2mo, range 9-48mo) diagnosed with Dravet syndrome. Cognitive and motor developmental age, derived from the Bayley Scales of Infant Development or through standardized neurodevelopmental assessment, were converted into cognitive and motor developmental quotients. Multiple test scores per child were included.

Results: A strong positive relation was found between cognitive and motor developmental quotient (Pearson r=0.854; p<0.001) in 20 children (slope=0.75; 95% CI: 0.54-0.95). A later age of independent walking was associated with a lower cognitive developmental quotient (28 children; p<0.001; slope=-1.01; 95% CI: -1.53 to -0.49). A higher cognitive developmental quotient was seen in children with an age at testing younger than 24 months. The cognitive developmental quotient of children with a delay in independent walking (>17.6mo) was significantly lower than those without a delay (p=0.006).

Interpretation: A strong relation exists between cognitive and motor development. Furthermore, the age of independent walking might be an important indicator of the development of children with Dravet syndrome.

What this paper adds: Cognitive and motor development are strongly related in children with Dravet syndrome. Later age of independent walking is associated with worse cognitive development in children with Dravet syndrome.

© 2020 Mac Keith Press.

References

    1. Dravet C. Dravet syndrome history. Dev Med Child Neurol 2011; 53(Suppl. 2): 1-6.
    1. Rosander C, Hallböök T. Dravet syndrome in Sweden: a population-based study. Dev Med Child Neurol 2015; 57: 628-33.
    1. Wolff M, Cassé-Perrot C, Dravet C. Severe myoclonic epilepsy of infants (Dravet syndrome): natural history and neuropsychological findings. Epilepsia 2006; 47(Suppl. 2): 45-8.
    1. Ceulemans B. Overall management of patients with Dravet syndrome. Dev Med Child Neurol 2011; 53(Suppl. 2): 19-23.
    1. Battaglia D, Chieffo D, Siracusano R, et al. Cognitive decline in Dravet syndrome: is there a cerebellar role? Epilepsy Res 2013; 106: 211-21.
    1. Chieffo D, Battaglia D, Lettori D, et al. Neuropsychological development in children with Dravet syndrome. Epilepsy Res 2011; 95: 86-93.
    1. Nabbout R, Chemaly N, Chipaux M, et al. Encephalopathy in children with Dravet syndrome is not a pure consequence of epilepsy. Orphanet J Rare Dis 2013; 8: 176.
    1. Riva D, Vago C, Pantaleoni C, Bulgheroni S, Mantegazza M, Franceschetti S. Progressive neurocognitive decline in two children with Dravet syndrome, de novo SCN1A truncations and different epileptic phenotypes. Am J Med Genet 2009; 149A: 2339-45.
    1. Ragona F. Cognitive development in children with Dravet syndrome. Epilepsia 2011; 52(Suppl. 2): 39-43.
    1. Villeneuve N, Laguitton V, Viellard M, et al. Cognitive and adaptive evaluation of 21 consecutive patients with Dravet syndrome. Epilepsy Behav 2014; 31: 143-8.
    1. Chieffo D, Ricci D, Baranello G, et al. Early development in Dravet syndrome; visual function impairment precedes cognitive decline. Epilepsy Res 2011; 93: 73-9.
    1. Petrelli C, Passamonti C, Cesaroni E, et al. Early clinical features in Dravet syndrome patients with and without SCN1A mutations. Epilepsy Res 2012; 99: 21-7.
    1. Ragona F, Bazzo D, De Giorgi I, et al. Dravet syndrome: early clinical manifestations and cognitive outcome in 37 Italian patients. Braindev 2010; 32: 71-7.
    1. Ricci D, Chieffo D, Battaglia D, et al. A prospective longitudinal study on visuo-cognitive development in Dravet syndrome: is there a ‘dorsal stream vulnerability’? Epilepsy Res 2015; 109: 57-64.
    1. Verheyen K, Verbecque E, Ceulemans B, Schoonjans A-S, Van de Walle P, Hallemans A. Motor development in children with Dravet syndrome. Dev Med Child Neurol 2019; 61: 950-6.
    1. De Lange I, Gunning B, Sonsma A, et al. Outcomes and comorbidities of SCN1A-related seizure disorders. Epilepsy Behav 2019; 90: 252-9.
    1. Lagae L, Brambilla I, Mingorance A, Gibson E, Battersby A. Quality of life and comorbidities associated with Dravet syndrome severity: a multinational cohort survey. Dev Med Child Neurol 2018; 60: 63-72.
    1. Di Marco R, Hallemans A, Bellon G, et al. Gait abnormalities in people with Dravet syndrome: a cross-sectional multi-center study. Eur J Paediatr Neuro 2019; 23: 808-18.
    1. de Lange I, Gunning B, Sonsma A, et al. Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A-related seizure phenotypes. Epilepsia 2018; 59: 1154-1165.
    1. WHO Multicentre Growth Reference Study Group. WHO Motor Development Study: windows of achievement for six gross motor development milestones. Acta Paediatr 2006; 450: 86-95.
    1. Majnemer A, Rosenblatt B. Reliability of parental recall of developmental milestones. Pediatr Neurol 1994; 10: 304-8.
    1. von Elm E, Altman D, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008; 61: 344-9.
    1. Scheffer I, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology. Epilepsia 2017; 58: 512-21.
    1. Diamond A. Close interrelation of motor development and cognitive development and of the cerebellum and prefrontal cortex. Child Dev 2000; 71: 44-56.
    1. Battaglia D, Ricci D, Chieffo D, Guzzetta F. Outlining a core neuropsychological phenotype for Dravet syndrome. Epilepsy Res 2016; 120: 91-7.
    1. Brunklaus A, Ellis R, Reavey E, Forbes G, Zuberi S. Prognostic clinical and demographic features in SCN1A mutation-positive Dravet syndrome. Brain 2012; 135: 2329-36.
    1. Guerrini R, Dravet C, Genton P, Belmonte A, Kaminska A, Dulac O. Lamotrigine and seizure aggravation in sever myoclonic epilepsy. Epilepsia 1998; 39: 508-12.
    1. Sharp M, DeMauro S. Counterbalanced Ccmparison of the BSID-II and Bayley-III at eighteen to twenty-two months corrected age. J Dev Behav Pediatr 2017; 38: 322-9.
    1. Yi YG, Sung IY, Yuk JS. Comparison of second and third editions of the Bayley Scales in children with suspected developmental delay. Ann Rehabil Med 2018; 42: 313-20.
    1. Langendonck J, van Beijsterveldt C, Brouwer S, Stroet T, Hudziak J, Doomsma D. Assessment of motor milestones in twins. Twin Res Hum Gen 2007; 10: 835-9.
    1. Gitiaux C, Chemaly N, Quijano-Roy S, et al. Motor neuropathy contributes to crouching in patients with Dravet syndrome. Neurology 2016; 87: 277-81.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner